About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life,…
Cookies?
A session cookie keeps you signed in. If you accept, we also use analytics cookies (Google Analytics and PostHog) to understand usage. Learn more
We couldn't check your fit for this role — add a CV to your profile to see it next time.